About psilocybin therapy

This page explains investigational psilocybin therapy, also described as psilocybin treatment, and how it is being studied with psychological support for certain mental health conditions. It notes that COMPASS Pathways has developed an investigational synthesised formulation of psilocybin called COMP360. The content covers what happens during psilocybin therapy, including preparation, the dosing session, and integration afterward. It describes the session environment, the role of the therapist, and the use of music and an eye mask during the experience. The page is primarily informational and also outlines COMPASS Pathways’ clinical development programme and the conditions being researched, including treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa.